Eccrine hidrocystoma
☆ Fir-riżultati ta' Stiftung Warentest tal-2022 mill-Ġermanja, is-sodisfazzjon tal-konsumatur b'ModelDerm kien biss ftit inqas milli b'konsultazzjonijiet bit-telemediċina mħallsa.
Jippreżenta bħala papules blu żgħar mimlija b'likwidu ċar.
References
Eccrine hidrocystomas (EHs) huma tumuri beninni li jiffurmaw minn kanali tal-għaraq ekrini minfuħin. Ħafna drabi jdumu għal żmien twil u jistgħu jmorru għall-agħar waqt temp sħun meta l-għaraq tiżdied. L-EH normalment tiġi djanjostikata abbażi tas-sintomi, iżda bijopsija tal-ġilda tista' tikkonfermaha. Aħna nippreżentaw żewġ każijiet ta 'EH, li jiffokaw fuq il-karatteristiċi dermoskopiċi tagħhom u t-trattament b'suċċess b'peptide topiku simili għat-tossina botulinum.
Eccrine hidrocystomas (EHs) are benign tumors, which arise as cystic dilatation of the eccrine sweat duct. The lesions of EH have a chronic course with periodic flares in summer months, associated with exacerbation in sweating. Diagnosis is mainly clinical with histopathology being confirmatory. Dermoscopy is a noninvasive tool, which may confirm diagnosis of EH without subjecting the patient to a biopsy. We report two representative cases of EH, with emphasis on dermoscopic features and which well responded to topical botulinum toxin-like peptide.
Eccrine hidrocystomas (EHs) are benign tumors, which arise as cystic dilatation of the eccrine sweat duct. The lesions of EH have a chronic course with periodic flares in summer months, associated with exacerbation in sweating. Diagnosis is mainly clinical with histopathology being confirmatory. Dermoscopy is a noninvasive tool, which may confirm diagnosis of EH without subjecting the patient to a biopsy. We report two representative cases of EH, with emphasis on dermoscopic features and which well responded to topical botulinum toxin-like peptide.
○ Trattament
It-tkessiħ taż-żona affettwata jista 'jnaqqas temporanjament id-daqs taż-żona affettwata.
It-trattament bil-lejżer huwa normalment ineffettiv.